Accessibility Menu
Cosmos Health logo

Cosmos Health(NASDAQ) COSM

Market Cap$12.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)-100%
5 YearN/A
1 Year-77%
1 Month+7%
$0.22
+7.45%
+0.01Today
After hours$0.21-$0.01 (-2.33%)
Cosmos Health last closing stock price
MetricPriceDate
Last closeUSD 0.222026-07-31
Cosmos Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+7.85%USD 0.202026-07-24
1 month+6.94%USD 0.202026-07-01
3 month-43.2%USD 0.382026-05-01
Year to date-56.71%USD 0.502025-12-31
1 year-76.69%USD 0.922025-07-31
3 year-85.33%USD 1.472023-08-01
Since inception-99.87%USD 157.502013-09-30

Cosmos Health Financials at a Glance

Market Cap

$12.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$69.49M

Net Income (TTM)

-$21.13M

EPS (TTM)

-$0.65

P/E Ratio

-0.31

Dividend

$0.00

Beta (Volatility)

1.08 (Average)

Price

$0.22

Volume

5,027,089.384

Open

$0.20

Previous Close

$0.22

Daily Range

$0.20 - $0.22

52-Week Range

$0.16 - $1.32

Estimated Earnings Date

Aug 17, 2026

COSM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cosmos Health

Cosmos Health makes medicines, vitamins, and health products for daily needs. Pharmacies and distributors use these products to help patients and consumers. Its offerings support health, wellness, and basic care for many people.

What’s in the Medicine Cabinet?

  • Nutraceuticals & Pharmaceuticals (5.7%): Products under brands like Sky Premium Life, including vitamins, minerals, and other pharmaceutical and nutraceutical offerings aimed at wellness-focused consumers.
  • Pharma Manufacturing (2.8%): Contract manufacturing services for other companies, including drug production and packaging.
  • Biocides & Antiseptics: Antimicrobial and antiseptic products for infection control in healthcare and home settings.
  • Medical Devices & Baby Care: Devices and organic infant care products for families and healthcare providers.

Growth Spurts and New Directions

  • Acquired ZipDoctor (telehealth) in April 2023; exited telehealth focus in 2024.
  • Acquired Bikas (pharmaceutical distribution) in June 2023, expanding Greek market reach.
  • Signed exclusive UAE distribution for Sky Premium Life in June 2024.
  • Bought Cloudscreen (AI drug repurposing) in January 2024 to boost R&D.
  • Expanded contract manufacturing via Cana S.A. in 2024.

What Makes Cosmos Health Stand Out

Cosmos Health controls its supply chain from research to distribution, helping manage costs and quality. Its automated warehouses and proprietary brands support efficiency and product differentiation in a crowded market.

Five Things You Need to Know

  • Q2 2025 revenue was $14,745,702, up 11.7% from Q2 2024.
  • Gross profit for Q2 2025 was $1,163,814, up 51.7% year-over-year.
  • Net loss for Q2 2025 was $2,828,068, 9.2% higher than Q2 2024.
  • Cash at June 30, 2025 was $655,503, with negative working capital of $604,249.
  • Wholesale distribution made up 91.5% of revenue for the first half of 2025.

Bottom Line

Cosmos Health has grown through acquisitions, new products, and global partnerships. The company remains focused on health essentials, but faces ongoing financial and operational challenges.

AI Generated • Apr 16, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

163

CEO

Grigorios Siokas

Website

www.cosmosholdingsinc.com

Headquarters

Thessaloniki, IL 55438, GR

COSM Financials

Key Financial Metrics (TTM)

Gross Margin

10.40%

Operating Margin

-25.75%

Net Income Margin

-30.41%

Return on Equity

-96.48%

Return on Capital

-43.08%

Return on Assets

-33.88%

Earnings Yield

-3.23%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

62.08M

Volume

5.03M

Avg. Volume

9.40M

Financials (TTM)

Gross Profit

$7.23M

Operating Income

-$17.89M

EBITDA

-$16.69M

Operating Cash Flow

-$10.84M

Capital Expenditure

-$246.60K

Free Cash Flow

-$11.09M

Cash & ST Invst.

$548.93K

Total Debt

$17.42M

Cosmos Health Performance Analysis

Cosmos Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 50,347,652-10.5%
20232023-12-31USD 53,376,8746.0%
20242024-12-31USD 54,426,4022.0%
20252025-12-31USD 65,271,81519.9%
Cosmos Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-307.5%
Q32025-09-3016.0%
Q42025-12-3115.2%
Q12026-03-31-9.0%
Cosmos Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -33.1639.7%
20232023-12-31USD -2.15-93.5%
20242024-12-31USD -1.17-45.8%
20252025-12-31USD -0.63-45.9%
Cosmos Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-213.4%
Q32025-09-30-72.8%
Q42025-12-31-94.1%
Q12026-03-3181.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$17.93M

+30.7%

Gross Profit

$1.38M

-32.6%

Gross Margin

7.70%

N/A

Market Cap

$12.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$76.21K

N/A

Employees

163

N/A

Net Income

-$2.81M

-242.9%

EBITDA

-$1.64M

-429.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$548.93K

-28.5%

Total Debt

$17.42M

+35.6%

Accounts Receivable

$21.46M

+25.4%

Inventory

$5.65M

+19.3%

Long Term Debt

$6.59M

+157.6%

Short Term Debt

$10.83M

+5.3%

Return on Assets

-33.88%

N/A

Return on Invested Capital

-63.24%

N/A

Free Cash Flow

-$1.08M

-438.9%

Operating Cash Flow

-$1.07M

-472.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PASGPassage Bio, Inc.
$4.47-0.45%
LSTALisata Therapeutics, Inc.
$0.99-3.88%
FEMYFemasys Inc.
$2.86-1.72%
NCNANuCana plc
$1.32+4.76%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About COSM

What is the current price of Cosmos Health?

Cosmos Health is trading at $0.22 per share.

What is the 52-week range for Cosmos Health?

Over the past 52 weeks, Cosmos Health has traded between $0.16 and $1.32.

How much debt does Cosmos Health have?

As of the most recent reporting period, Cosmos Health reported total debt of $18.48M.

How much cash does Cosmos Health have on hand?

Cosmos Health reported $2.16M in cash and cash equivalents in its most recent financial results.

What is Cosmos Health’s dividend yield?

Cosmos Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services